DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression.

Author(s): Robinson RG, Tenev V, Jorge RE

Affiliation(s): Department of Psychiatry, Carver College of Medicine, University of Iowa, IA, USA. robert-robinson@uiowa.edu

Publication date & source: 2009-08, Am J Geriatr Psychiatry., 17(8):682-7.

Publication type: Randomized Controlled Trial; Research Support, N.I.H., Extramural

OBJECTIVES: The authors previously reported that repetitive transcranial magnetic stimulation (rTMS) produced a response rate of 39.4% among 62 patients with treatment resistant vascular depression. This study was undertaken to assess the outcome of continuation therapy to prevent relapse among these patients during 9 weeks after completion of rTMS. DESIGN: Patients were randomly assigned to 18,000 pulses of rTMS given over 3 weeks or sham treatment using double blind methods. After rTMS, all patients were given 20 mg/day of citalopram for 9 weeks and reevaluated at 3, 6, and 9 weeks. SETTING: Outpatient continuation treatment trial. PARTICIPANTS: Patients with vascular depression (N = 62), as determined by magnetic resonance imaging hyperintensities and three or more clinical risk factors for vascular disease without other major medical illness, were recruited. They had onset of major depression after age 50 and failed at least one trial of antidepressants. INTERVENTION: After rTMS or sham treatment, all treatment responders were given citalopram for 9 weeks. RESULTS: Among the 33 patients who were given rTMS, 13 responded (i.e., >50% decline in Hamilton Depression Scale score). Of these 13, all completed the 9 weeks of continuation treatment. There were nine patients who continued to be responders and four who had a relapse of depression. CONCLUSION: More effective methods are needed to treat elderly patients with treatment resistant vascular depression and to prevent relapse among treatment responders.

Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017